Sun Pharma to acquire remaining stake in subsidiary Taro for $348 million Sun Pharma has announced its intention to acquire the remaining shares of its Israeli subsidiary, Taro Pharma, at a rate of $43 per.. IndiaTimes 18 Jan 2024